Editorial: the microscope holds the key to predict need for biologic therapy in immunotherapy-checkpoint inhibitory colitis. Authors' reply.

Saved in:
Bibliographic Details
Title: Editorial: the microscope holds the key to predict need for biologic therapy in immunotherapy-checkpoint inhibitory colitis. Authors' reply.
Authors: Pai RK; Department of Laboratory Medicine & Pathology, Mayo Clinic Arizona, Scottsdale, AZ, USA., Pai RK; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Schaeffer DF; Department of Pathology, University of British Columbia, Vancouver, BC, Canada., Choi WT; Department of Pathology, University of California San Francisco, San Francisco, CA, USA., Kumarasinghe P; Department of Anatomical Pathology, PathWest Laboratory Medicine and University of Western Australia, Perth, WA, Australia., Brown I; Envoi Specialist Pathologists, Brisbane, QLD, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia., Lauwers GY; Department of Pathology, Henry L. Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Mar; Vol. 53 (5), pp. 638-639.
Publication Type: Editorial; Comment
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2036
DOI:10.1111/apt.16245